Human medicinal products
SPC PL
Veterinary medicinal
products
SPC PL
Herbal medicinal products
SPC PL
Name of the medicinal
product
A B C D E F G
H I J K L M N
O P Q R S T U
V W X Y Z Å Ä Ö
Name of the medicinal
product

Marketing authorisation
holder

Marketing authorisation
number

ATC Code Codes

Free text search

Active agent

Pharmaceutical form

Adverse effect

Therapeutic indication

Contraindication

Insert text in the fields in Finnish


Summaries of Product Characteristics (SPC) for Human medicinal products

The summaries of product characteristics (SPC) contain the information relevant to the use of the medicinal products and of importance to health care professionals. The SPCs are published in Finnish; the use of Finnish key words in the search fields is therefore recommended.

Some of the medicinal products contain a condition relevant to the prescribing of the product and not always found in the SPC. The conditions for prescribing and the products covered by this condition are found in the FimeaWeb search.

The SPCs processed as part of the EU centralised marketing authorisation procedure are published by the European Medicines Agency, EMA. Fimea's service contains links to the documents on medicinal products (EPAR PI) on the EMA website. Drugs belonging to the centralised authorisation procedure can be searched in Fimea's service by using an alphabetical list or by entering the product name or ATC code.

The material being published is not necessarily complete or up-to-date due to the technical quality of files submitted to the Finnish Medicines Agency Fimea or earlier to the National Agency for Medicines and the delays in delivery. For this reason, Fimea cannot guarantee that the document on the Internet fully complies with the summary of product characteristics and package leaflet officially approved by a desicion for a marketing authorisation. Only the hard copies of the SPCs and the PLs, which are in accordance with the marketing authorisation, are conclusive.


Summaries of Product Characteristics 151 - 180 of 263
Previous 30    |  1  2  3  4  5  6  7  8  9  |  Next 30   >    
Package
leaflet
Status for
supply
Name of the medicinal product

PL

Resepti

Rivaroxaban Avansor 10 mg tabletti, kalvopäällysteinen SPC 2020-12-03

PL

Resepti

Rivaroxaban Avansor 15 mg, 20 mg tabletti, kalvopäällysteinen SPC 2020-12-03

PL

Resepti

Rivaroxaban Avansor 2,5 mg tabletti, kalvopäällysteinen SPC 2020-12-03

PL

Resepti

Rivaroxaban Krka 10 mg tabletti, kalvopäällysteinen SPC 2024-03-13

PL

Resepti

Rivaroxaban Krka 15 mg tabletti, kalvopäällysteinen SPC 2024-03-13

PL

Resepti

Rivaroxaban Krka 2,5 mg tabletti, kalvopäällysteinen SPC 2024-03-13

PL

Resepti

Rivaroxaban Krka 20 mg tabletti, kalvopäällysteinen SPC 2024-03-13

PL

Resepti

Rivaroxaban Orion 10 mg tabletti, kalvopäällysteinen SPC 2023-08-25

PL

Resepti

Rivaroxaban Orion 15 mg, 20 mg tabletti, kalvopäällysteinen SPC 2023-11-10

PL

Resepti

Rivaroxaban Orion 2.5 mg tabletti, kalvopäällysteinen SPC 2023-08-25

PL

Resepti

Rivaroxaban ratiopharm 10 mg tabletti, kalvopäällysteinen SPC 2023-12-20

PL

Resepti

Rivaroxaban ratiopharm 15 mg tabletti, kalvopäällysteinen SPC 2023-12-20

PL

Resepti

Rivaroxaban ratiopharm 15 mg, 20 mg tabletti, kalvopäällysteinen SPC 2023-12-20 aloituspakkaus

PL

Resepti

Rivaroxaban ratiopharm 2,5 mg tabletti, kalvopäällysteinen SPC 2023-12-20

PL

Resepti

Rivaroxaban ratiopharm 20 mg tabletti, kalvopäällysteinen SPC 2023-12-20

PL

Resepti

Rivaroxaban Sandoz 10 mg tabletti, kalvopäällysteinen SPC 2024-02-06

PL

Resepti

Rivaroxaban Sandoz 15 mg tabletti, kalvopäällysteinen SPC 2024-02-06

PL

Resepti

Rivaroxaban Sandoz 2,5 mg tabletti, kalvopäällysteinen SPC 2024-02-06

PL

Resepti

Rivaroxaban Sandoz 20 mg tabletti, kalvopäällysteinen SPC 2024-02-06

PL

Resepti

Rivaroxaban Stada 10 mg tabletti, kalvopäällysteinen SPC 2023-08-23

PL

Resepti

Rivaroxaban Stada 15 mg + 20 mg tabletti, kalvopäällysteinen SPC 2023-08-23

PL

Resepti

Rivaroxaban Stada 15 mg kapseli, kova SPC 2023-08-16

PL

Resepti

Rivaroxaban Stada 15 mg tabletti, kalvopäällysteinen SPC 2023-08-23

PL

Resepti

Rivaroxaban Stada 15 mg, 20 mg kapseli, kova hoidon aloituspakkaus SPC 2023-08-16

PL

Resepti

Rivaroxaban Stada 2,5 mg tabletti, kalvopäällysteinen SPC 2023-08-23

PL

Resepti

Rivaroxaban Stada 20 mg kapseli, kova SPC 2023-08-16

PL

Resepti

Rivaroxaban Stada 20 mg tabletti, kalvopäällysteinen SPC 2023-08-23

European Medicines Agency's website:
Rivaroxaban Viatris (ent. Rivaroxaban Mylan) - EMA: EPAR PI
Finnish Swedish

PL

Resepti

Rivastigmin Orion 1,5 mg, 3 mg, 4,5 mg, 6 mg kapseli, kova SPC 2023-07-04

PL

Resepti

Rivastigmin Stada 1.5 mg, 3 mg, 4.5 mg, 6 mg kapseli, kova SPC 2020-12-09

Previous 30    |  1  2  3  4  5  6  7  8  9  |  Next 30   >